Ann: Launch of Australian and International Medicines Supply, page-26

A year ago they did not have the licenses they needed , they do now.

While the framework for the legitimate access to cannabis in Australia has
historically been highly restrictive and complex, recent regulatory reforms are
expected to improve access to medicinal cannabis with the patient population
expected to reach 330,000 by 2025. Additionally, the industrial applications of
cannabis and hemp present compelling opportunities including agricultural use and the
production of hemp rope and other fabrics.

The cannabis cultivation and manufacturing industries in Australia are in their
infancy.

The sourcing of legitimate imported cannabis products can be a complex
process, the expense of which is passed onto the consumer. Accordingly, there is
considerable impetus for the development of the Australian cannabis market.

THC is focused on the manufacturing and agricultural distribution of
hydroponics equipment, materials and nutrients; large-scale
hydroponic greenhouse design and construction; and the
development and delivery of medicinal cannabis to undercut others
in distribution hopefully global but definitely Australia. .

Most others in OZ are supplied by overseas sources
and do not have the inhouse manufacturing capabilities
THC has.

I will reiterate on my previous post as i feel it is relevant and
important to the discussion..

"Only in 2019 was major sales production predictions made by management for any year
other than 2020, not before, and licences were a huge issue
such is the way OZ regulations are, now we have what we needed."

I do expect a relevantly big show financially from them by year end with
positive ANNs relating to income in the coming months
those that want to make a quick million will have to wait a bit longer.